Burden of Atopic Dermatitis in China and Its Provinces, 1990–2021: A Global Burden of Disease 2021 Analysis
International Journal of Dermatology · 2025
DOI: 10.1111/ijd.70085 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Dermatology, 2025. Verfasst von Weijia Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology and Venereology Department, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China Youth Fund Project, Guangzhou Health Commission General Project.
Abstract (Originalsprache)
Background
Atopic dermatitis (AD) has a high disease burden worldwide. However, the specific impact and geographical variations of AD in China remain unclear.
Methods
Using Global Burden of Disease (GBD) 2021 data, we assessed the AD burden (incidence, prevalence, and years lived with disability [YLDs]) across China's 33 provinces (1990–2021). Joinpoint regression analysis was used to identify temporal trends. We examined how urbanization and the human development index (HDI) influence the AD burden.
Results
In 2021, China had 2.17 million (95% uncertainty interval [UI]: 2.08–2.26) new AD cases, 15.42 million (95% UI: 14.84–16.00) patients, and 0.68 million (95% UI: 0.35–1.14 million) YLDs. The crude incidence, prevalence, and YLD rates peaked in female individuals aged < 5 years of age and showed a decreasing gradient from South to North and West to East. Overall, all three rates slightly decrease from 1990 to 2021. Heterogeneity of time trends was observed across age groups, with rapid growth in patients aged < 5 years. Both the speed of urbanization and HDI were positively correlated with the incidence ( r urban = 0.52, r HDI = 0.48), prevalence ( r urban = 0.50, r HDI = 0.50), and YLD rates ( r urban = 0.61, r HDI = 0.62) of average annual percentage change in people aged < 5 years.
Conclusions
The disease burden due to AD is high in China, with a sharp increase in people aged < 5 years. Rapid urbanization may intensify this increase, making it crucial to develop comprehensive AD management strategies that account for urbanization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dermatology and Venereology Department, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China.
- Dermatology Hospital, Southern Medical University, Guangzhou, China.
- Southern Medical University Institute for Global Health, Guangzhou, China.
- National Centre for Chronic and Non-Communicable Disease Control and Prevention, Chinese Centre for Disease Control and Prevention, Beijing, China.
- The First School of Clinical Medicine, Southern Medical University, Guangzhou, China.
- School of Public Health, Southern Medical University, Guangzhou, China.
ORCID-Profile: Weijia Zhao, Pengpeng Ye, Bin Yang
Förderung
- National Natural Science Foundation of China Youth Fund Project
- Guangzhou Health Commission General Project
Zitieren
APA
Zhao, W., Ye, P., Yang, H., Yang, Y., Zhu, S., Cheung, H. J., Yang, B., Liang, Y., & Li, C. (2025). Burden of Atopic Dermatitis in China and Its Provinces, 1990–2021: A Global Burden of Disease 2021 Analysis. International Journal of Dermatology. https://doi.org/10.1111/ijd.70085
Vancouver
Zhao W, Ye P, Yang H, Yang Y, Zhu S, Cheung HJ, et al. Burden of Atopic Dermatitis in China and Its Provinces, 1990–2021: A Global Burden of Disease 2021 Analysis. International Journal of Dermatology. 2025. doi:10.1111/ijd.70085
BibTeX
@article{Zhao2025,
author = {Zhao, Weijia and Ye, Pengpeng and Yang, Haihui and Yang, Yunqing and Zhu, Shunmin and Cheung, Hajanirina Jade and Yang, Bin and Liang, Yunsheng and Li, Changchang},
title = {Burden of Atopic Dermatitis in China and Its Provinces, 1990–2021: A Global Burden of Disease 2021 Analysis},
journal = {International Journal of Dermatology},
year = {2025},
doi = {10.1111/ijd.70085}
}
EUVIMED